Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects
Frontiers in Psychiatry · 08.01.2024 · 14
DOI: 10.3389/fpsyt.2023.1302559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 08.01.2024. Verfasst von Helena D Aicher und 13 weiteren Autor:innen. Beteiligte Einrichtung: Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, Uni…. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
There is growing scientific evidence for the therapeutic benefits of the Amazonian plant-based psychedelic “ayahuasca” for neuropsychiatric disorders such as depression and anxiety. However, there are certain challenges when incorporating botanical ayahuasca into biomedical research and clinical therapy environments. Formulations inspired by ayahuasca, which contain specific and standardized active components, are a potential remedy.
Methods
We investigated subjective acute and persisting effects of a novel formulation containing the reversible monoamine oxidase inhibitor harmine (orodispersible tablet containing 100 mg MAO-I) and N,N-dimethyltryptamine (incremental intranasal dosing of up to 100 mg DMT), compared with two other conditions, namely harmine alone and placebo, in a crossover RCT in 31 healthy male subjects.
Results
DMT + harmine, but not harmine alone, induced a psychedelic experience assessed with the 5D-ASC rating scale [global score: F (2,60) = 80.21, p < 0.001] and acute experience sampling items over time, characterized by psychological insights [PIQ, F (2,58.5) = 28.514, p < 0.001], emotional breakthroughs [EBI, F (2,60) = 26.509, p < 0.001], and low scores on the challenging experience questionnaire [CEQ, F (2,60) = 12.84, p < 0.001]. Participants attributed personal and spiritual significance to the experience (GSR) with mainly positive persisting effects (PEQ) at 1- and 4-months follow-up. Acute drug effects correlated positively with persisting effects. We found no changes in trait measures of personality, psychological flexibility, or general well-being, and no increases in psychopathology (SCL-90-R) were reported. Discussion and Conclusion Our results suggest that the experience induced by the standardized DMT + harmine formulation induces a phenomenologically rich psychedelic experience, demonstrates good psychological safety and tolerability, is well tolerated, and induces beneficial psychological processes that could possibly support psychotherapy. Further studies are required to investigate the psychotherapeutic potential in patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Psychology, University of Zurich, Zurich, Switzerland.
- Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.
- Department of Health Science and Technology, ETH, Zurich, Switzerland.
- Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
- Department of Forensic Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Zitieren
APA
Aicher, H. D., Mueller, M. J., Dornbierer, D. A., Suay, D., Elsner, C., Wicki, I., Meling, D., Caflisch, L., Hempe, A., Steinhart, C., Mueller, J., Von Rotz, R., Kleim, B., & Scheidegger, M. (2024). Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1302559
Vancouver
Aicher HD, Mueller MJ, Dornbierer DA, Suay D, Elsner C, Wicki I, et al. Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. Frontiers in Psychiatry. 2024;14. doi:10.3389/fpsyt.2023.1302559
BibTeX
@article{Aicher2024,
author = {Aicher, Helena D and Mueller, Michael J and Dornbierer, Dario A and Suay, Dila and Elsner, Claudius and Wicki, Ilhui and Meling, Daniel and Caflisch, Luzia and Hempe, Alexandra and Steinhart, Camilla and Mueller, Jovin and Von Rotz, Robin and Kleim, Birgit and Scheidegger, Milan},
title = {Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects},
journal = {Frontiers in Psychiatry},
year = {2024},
volume = {14},
doi = {10.3389/fpsyt.2023.1302559}
}
EUVIMED